Morgan Stanley’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.61K Sell
326
-15
-4% -$120 ﹤0.01% 7170
2025
Q1
$2.41K Sell
341
-40,281
-99% -$285K ﹤0.01% 7136
2024
Q4
$461K Buy
40,622
+39,950
+5,945% +$453K ﹤0.01% 5446
2024
Q3
$9.41K Hold
672
﹤0.01% 6733
2024
Q2
$10.7K Sell
672
-20
-3% -$318 ﹤0.01% 6662
2024
Q1
$18.7K Sell
692
-692
-50% -$18.7K ﹤0.01% 6511
2023
Q4
$28K Sell
1,384
-7,462
-84% -$151K ﹤0.01% 6547
2023
Q3
$116K Buy
8,846
+3,286
+59% +$43.2K ﹤0.01% 5817
2023
Q2
$105K Sell
5,560
-7,999
-59% -$151K ﹤0.01% 5936
2023
Q1
$260K Buy
13,559
+11,691
+626% +$224K ﹤0.01% 5585
2022
Q4
$51.6K Sell
1,868
-23,255
-93% -$642K ﹤0.01% 6278
2022
Q3
$629K Sell
25,123
-27,425
-52% -$687K ﹤0.01% 5147
2022
Q2
$2.48M Buy
52,548
+19,377
+58% +$914K ﹤0.01% 4364
2022
Q1
$2.06M Sell
33,171
-44,434
-57% -$2.76M ﹤0.01% 4505
2021
Q4
$9.86M Buy
77,605
+20,433
+36% +$2.6M ﹤0.01% 2969
2021
Q3
$11.4M Sell
57,172
-145
-0.3% -$28.9K ﹤0.01% 2744
2021
Q2
$15.2M Buy
57,317
+27,027
+89% +$7.16M ﹤0.01% 2489
2021
Q1
$10.6M Buy
30,290
+9,073
+43% +$3.17M ﹤0.01% 2580
2020
Q4
$10.9M Buy
21,217
+738
+4% +$377K ﹤0.01% 2427
2020
Q3
$5.37M Buy
20,479
+871
+4% +$228K ﹤0.01% 2658
2020
Q2
$10.7M Buy
19,608
+4,975
+34% +$2.72M ﹤0.01% 1903
2020
Q1
$4.61M Buy
+14,633
New +$4.61M ﹤0.01% 2535